The Best Drug Companies Of The Decade
This data comes from Bernard Munos, who has become an unlikely innovation guru for the drug-discovering set. Munos argues that Novartis’ success has resulted from its tendency to bet on breakthrough innovations. Novartis tends to agree. Executives there say that they have been insisting that new drugs have substantial efficacy before they even consider approving them. Click here for a story on Munos’ prescriptions for pharma innovation from the current issue of Forbes Magazine.
Ver anterior:
Entradas
No hay comentarios:
Publicar un comentario